BIOMAT Database Logo BIOMAT Database Logo

COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it? 2021

Arnaud Fekkar, and Dionysios Neofytos, and Minh-Hong Nguyen, and Cornelius J Clancy, and Dimitrios P Kontoyiannis, and Frederic Lamoth
AP-HP, Groupe Hospitalier La Pitié-Salpêtrière, Service de Parasitologie Mycologie, Paris, France. Electronic address: arnaud.fekkar@aphp.fr.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D055744 Invasive Pulmonary Aspergillosis Lung infections with the invasive forms of ASPERGILLUS, usually after surgery, transplantation, prolonged NEUTROPENIA or treatment with high-doses of CORTICOSTEROIDS. Invasive pulmonary aspergillosis can progress to CHRONIC NECROTIZING PULMONARY ASPERGILLOSIS or hematogenous spread to other organs. Allergic Bronchopulmonary Mycosis,Chronic Necrotizing Pulmonary Aspergillosis,Pulmonary Aspergillosis - Invasive,Allergic Bronchopulmonary Mycoses,Aspergillosis, Invasive Pulmonary,Bronchopulmonary Mycoses, Allergic,Bronchopulmonary Mycosis, Allergic,Mycoses, Allergic Bronchopulmonary,Mycosis, Allergic Bronchopulmonary,Pulmonary Aspergilloses, Invasive,Pulmonary Aspergillosis Invasive,Pulmonary Aspergillosis, Invasive
D060085 Coinfection Simultaneous infection of a host organism by two or more pathogens. In virology, coinfection commonly refers to simultaneous infection of a single cell by two or more different viruses. Mixed Infection,Co-infection,Polymicrobial Infection,Secondary Infection,Secondary Infections,Co infection,Co-infections,Coinfections,Infection, Mixed,Infection, Polymicrobial,Infection, Secondary,Infections, Mixed,Infections, Polymicrobial,Infections, Secondary,Mixed Infections,Polymicrobial Infections

Related Publications

Arnaud Fekkar, and Dionysios Neofytos, and Minh-Hong Nguyen, and Cornelius J Clancy, and Dimitrios P Kontoyiannis, and Frederic Lamoth
COVID-19-Associated Pulmonary Aspergillosis (CAPA).
October 2021, Journal of intensive medicine,
Arnaud Fekkar, and Dionysios Neofytos, and Minh-Hong Nguyen, and Cornelius J Clancy, and Dimitrios P Kontoyiannis, and Frederic Lamoth
COVID-19 associated pulmonary aspergillosis (CAPA) in a pregnant woman.
January 2021, Autopsy & case reports,
Arnaud Fekkar, and Dionysios Neofytos, and Minh-Hong Nguyen, and Cornelius J Clancy, and Dimitrios P Kontoyiannis, and Frederic Lamoth
Two cases of COVID-19-associated pulmonary aspergillosis (CAPA).
April 2022, Respirology case reports,
Arnaud Fekkar, and Dionysios Neofytos, and Minh-Hong Nguyen, and Cornelius J Clancy, and Dimitrios P Kontoyiannis, and Frederic Lamoth
COVID-19 associated pulmonary aspergillosis (CAPA): An Australian case report.
March 2021, Medical mycology case reports,
Arnaud Fekkar, and Dionysios Neofytos, and Minh-Hong Nguyen, and Cornelius J Clancy, and Dimitrios P Kontoyiannis, and Frederic Lamoth
COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment.
June 2020, Journal of fungi (Basel, Switzerland),
Arnaud Fekkar, and Dionysios Neofytos, and Minh-Hong Nguyen, and Cornelius J Clancy, and Dimitrios P Kontoyiannis, and Frederic Lamoth
A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA).
December 2021, Journal of fungi (Basel, Switzerland),
Arnaud Fekkar, and Dionysios Neofytos, and Minh-Hong Nguyen, and Cornelius J Clancy, and Dimitrios P Kontoyiannis, and Frederic Lamoth
COVID-19 associated pulmonary aspergillosis. A real problem?
April 2022, Minerva anestesiologica,
Arnaud Fekkar, and Dionysios Neofytos, and Minh-Hong Nguyen, and Cornelius J Clancy, and Dimitrios P Kontoyiannis, and Frederic Lamoth
COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
February 2023, Infection,
Arnaud Fekkar, and Dionysios Neofytos, and Minh-Hong Nguyen, and Cornelius J Clancy, and Dimitrios P Kontoyiannis, and Frederic Lamoth
Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review.
July 2021, The Journal of hospital infection,
Arnaud Fekkar, and Dionysios Neofytos, and Minh-Hong Nguyen, and Cornelius J Clancy, and Dimitrios P Kontoyiannis, and Frederic Lamoth
Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave.
January 2022, Journal of fungi (Basel, Switzerland),
Copied contents to your clipboard!